859621.fig.002a
(a)
859621.fig.002b
(b)
859621.fig.002c
(c)
859621.fig.002d
(d)
859621.fig.002e
(e)
859621.fig.002f
(f)
Figure 2: Digitized images showing some of the clinical aspects of the animals at the end of the experimental period; note the area of fur loss (star) and fistula (inside the circle) on the animal from the DA+CP group. C: control group, A: acetone group, CP: carbamide peroxide group, A+CP: acetone and carbamide peroxide group, DA+CP: 1% DMBA in acetone and carbamide peroxide group, DA+CP+S: 1% DMBA in acetone and carbamide peroxide, and treatment with sunitinib group.